StonvexLoading…
StonvexStonvexStonvexCore line items from BCHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.63M | $17.41M | $17.63M | $21.62M |
Operating Income | $-3.03M | $-7.16M | $-8.97M | $903.99K |
Net Income | $-3.03M | $-10.80M | $5.67M | $-1.58M |
EPS (Diluted) | $-0.16 | $-0.57 | $0.06 | $-0.02 |
Total Assets | $9.24M | $10.26M | $28.31M | $9.34M |
Total Liabilities | $10.95M | $9.07M | $28.25M | $16.76M |
Cash & Equivalents | $2.25M | $3.46M | $20.94M | $1.50M |
Free Cash Flow OCF − CapEx | $-729.41K | $-4.91M | $19.23M | $60.26K |
Shares Outstanding | 19.46M | 19.24M | 94.36M | 93.09M |